Covered recipient · General Payments record
DANIEL S MILLER
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,687.75
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $412.89 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $175.11 | 19 |
| Biogen, Inc. | $90.10 | 1 |
| Regeneron Healthcare Solutions, Inc. | $44.56 | 2 |
| Astellas Pharma US Inc | $29.61 | 1 |
| Bausch & Lomb Americas Inc. | $23.03 | 1 |
| Tarsus Pharmaceuticals, Inc. | $22.87 | 1 |
| Harrow Eye, LLC | $13.82 | 1 |
| Oyster Point Pharma, Inc. | $13.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.12 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035941 | CMS |
| ABBVIE INC. | $2.60 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035943 | CMS |
| ABBVIE INC. | $2.11 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035945 | CMS |
| ABBVIE INC. | $2.37 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035947 | CMS |
| ABBVIE INC. | $2.80 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035949 | CMS |
| ABBVIE INC. | $28.65 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035951 | CMS |
| ABBVIE INC. | $4.63 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035953 | CMS |
| ABBVIE INC. | $21.57 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035955 | CMS |
| ABBVIE INC. | $2.11 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035957 | CMS |
| ABBVIE INC. | $6.73 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035959 | CMS |
| ABBVIE INC. | $33.25 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035961 | CMS |
| ABBVIE INC. | $5.67 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035963 | CMS |
| ABBVIE INC. | $7.29 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035965 | CMS |
| ABBVIE INC. | $4.38 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035967 | CMS |
| ABBVIE INC. | $3.72 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035969 | CMS |
| ABBVIE INC. | $29.68 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035971 | CMS |
| ABBVIE INC. | $5.40 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035973 | CMS |
| ABBVIE INC. | $3.17 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035975 | CMS |
| ABBVIE INC. | $4.86 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035977 | CMS |
| Astellas Pharma US Inc | $29.61 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139439360 | CMS |
| Bausch & Lomb Americas Inc. | $23.03 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140329269 | CMS |
| Biogen, Inc. | $90.10 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104807751 | CMS |
| Harrow Eye, LLC | $13.82 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145609911 | CMS |
| Oyster Point Pharma, Inc. | $13.79 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147420960 | CMS |
| Regeneron Healthcare Solutions, Inc. | $20.85 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114115329 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.71 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114115331 | CMS |
| Tarsus Pharmaceuticals, Inc. | $22.87 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139117428 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.